Achieve Life Sciences (ACHV) Non-Current Assets (2010 - 2026)

Achieve Life Sciences has disclosed Non-Current Assets across 17 years of filings, most recently posting $2.0 million for Q1 2026.

• Quarterly Non-Current Assets fell 13.32% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.0 million (down 13.31% YoY) and the FY2025 annual result came in at $1.9 million, down 12.23% from the prior year.
• Non-Current Assets grew to $2.0 million in Q1 2026, from $1.9 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $2.9 million in Q1 2022 and troughed at $1.9 million in Q4 2025.
• A 5-year average of $2.4 million and a median of $2.4 million in 2024 frame the typical range for Non-Current Assets.
• Biggest YoY gain for Non-Current Assets was 1.64% in 2025; the steepest drop was 16.88% in 2025.
• Tracing ACHV's Non-Current Assets over 5 years: stood at $2.6 million in 2022, then fell by 9.54% to $2.4 million in 2023, then retreated by 9.33% to $2.2 million in 2024, then fell by 12.23% to $1.9 million in 2025, then climbed by 7.52% to $2.0 million in 2026.
• Business Quant data shows ACHV's Non-Current Assets at $2.0 million in Q1 2026, $1.9 million in Q4 2025, and $2.0 million in Q3 2025.